4. May 2017 Daniel Kruse

Especially hemp food and pharmaceuticals face strong demand – Worldwide largest conference on industrial hemp in Cologne (Germany) in June 2017

Hemp is a multi-purpose crop, delivering fibres, shivs, seeds and pharmaceuticals. Currently, the fibre is used for light weight papers, insulation material and biocomposites. The shivs, the woody inner core of the stem, are used for animal bedding and construction. Hemp seeds, small nuts with a high nutritional value, can be consumed raw or pressed into hemp seed oil, which has an excellent and unique fatty acid profile. Both seeds and oil are used for human food and animal feed. The non-psychotropic Cannabinoid CBD is an interesting pharmaceutical material and food supplement ingredient also derived from industrial hemp.
Between 1993 and 1996, the cultivation of industrial hemp was legalised in most EU member states, others followed later. In 2011, the cultivation area decreased to its lowest value since 1994 (ca. 8,000 ha), but increased continuously in the years 2012 to 2016, to finally reach more than 33,000 ha in 2016. Today, the cultivation area for industrial hemp covers the largest area since the second world war.
The European Industrial Hemp Association (www.eiha.org) expects almost constant or moderately growing cultivation areas in the next years. The main cultivation areas are in France, the Netherlands, the Baltic Countries and in Romania. In recent years, many new European countries started or expanded their hemp cultivation, mainly to produce more hemp seeds for the health food market. In the last years, hemp food products have entered the mass consumer markets via supermarkets in Austria, Germany, The Netherlands and more countries.
But also the hemp fibre sector is expanding, covering the increasing demand of the automotive industry. European hemp fibres are the only natural fibre worldwide with an established sustainability certification (www.iscc-system.org).
Investments and market growth are especially high in non-psychotropic hemp extracts and for the Cannabinoid CBD, which is used in pharmaceutical applications as well as in the food supplement industry. Here, a patchwork of regulations in Europe is a barrier for faster market growth.
All of these topics will be highlighted and discussed at the biggest event on industrial hemp worldwide, the 14th International Conference of the European Industrial Hemp Association, 7 – 8 June 2017, Cologne (Germany) (www.eiha-conference.org). More than 300 participants from 40 countries are expected. It is the meeting point of the hemp industry worldwide. Don’t miss this unique opportunity to meet the pioneers in this fast expanding business sector in one place.